Mr. Chair, these are the 400 substances that I identified earlier as having those characteristics. Certainly, as a starting point, one would want to consider what kinds of mandatory timelines would we want in an amended act, in terms of proceeding to the next stage of screening, or whether screening is necessary at all, given the information that we have, whether virtual elimination should be proceeded with, and on what timelines. In order to help with the decisions about how to recommend amending the act, I mentioned that it might be useful for the committee to learn from the departments what that list of the 400 looks like, and what smaller categories of substances they may be looking at for even faster action within that 400, so that this committee can have some input into that.
Unfortunately, as I said, the categorization will be complete by September. I know the departments are thinking about how to proceed. Certainly the public would be well served by this committee's learning how that process is going to turn out, in terms of recommending what should happen even before the act is amended. That's why I identified earlier that difficult timeliness.